These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8015418)

  • 41. Evaluation of long-term co-administration of tobramycin and clarithromycin in a mature biofilm model of cystic fibrosis clinical isolates of Pseudomonas aeruginosa.
    Tré-Hardy M; Traore H; El Manssouri N; Vanderbist F; Vaneechoutte M; Devleeschouwer MJ
    Int J Antimicrob Agents; 2009 Oct; 34(4):370-4. PubMed ID: 19505804
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Serial determination of complement and specific antibody titres in Pseudomonas aeruginosa infection.
    Petrás G; Füst G; Adám MM
    Acta Microbiol Hung; 1984; 31(2):141-51. PubMed ID: 6464660
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Complement activation and C3 binding by serum-sensitive and serum-resistant strains of Pseudomonas aeruginosa.
    Schiller NL; Hatch RA; Joiner KA
    Infect Immun; 1989 Jun; 57(6):1707-13. PubMed ID: 2498205
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Role of lipopolysaccharide in opsonization and phagocytosis of Pseudomonas aeruginosa.
    Engels W; Endert J; Kamps MA; van Boven CP
    Infect Immun; 1985 Jul; 49(1):182-9. PubMed ID: 3924827
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A complement-sensitive mutant of Pseudomonas aeruginosa.
    Offredo-Hemmer C; Berche P; Véron M
    Ann Microbiol (Paris); 1983; 134A(3):281-94. PubMed ID: 6416122
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Assays for complement activation.
    Cooper NR
    Clin Lab Med; 1986 Mar; 6(1):139-55. PubMed ID: 2420509
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Complement activation by cigarette smoke.
    Robbins RA; Nelson KJ; Gossman GL; Koyama S; Rennard SI
    Am J Physiol; 1991 Apr; 260(4 Pt 1):L254-9. PubMed ID: 1902064
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Complement activation in shock associated with a surgically provoked bacteriaemia.
    Brandslund I; Teisner B; Hole P; Grudzinskas JG; Svehag SE
    Acta Pathol Microbiol Immunol Scand C; 1983 Feb; 91(1):51-7. PubMed ID: 6603095
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An in vivo model to study the pathobiology of infectious biofilms on biomaterial surfaces.
    Buret A; Ward KH; Olson ME; Costerton JW
    J Biomed Mater Res; 1991 Jul; 25(7):865-74. PubMed ID: 1918103
    [TBL] [Abstract][Full Text] [Related]  

  • 50. High levels of complement-activation capacity in sera from patients with cystic fibrosis correlate with high levels of IgG3 antibodies to Pseudomonas aeruginosa antigens and poor lung function.
    Pressler T; Jensen ET; Espersen F; Pedersen SS; Høiby N
    Pediatr Pulmonol; 1995 Aug; 20(2):71-7. PubMed ID: 8570305
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The extracellular polymer substance of Pseudomonas aeruginosa: too slippery for neutrophils to migrate on?
    Hansch GM; Brenner-Weiss G; Prior B; Wagner C; Obst U
    Int J Artif Organs; 2008 Sep; 31(9):796-803. PubMed ID: 18924091
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The excessive complement activation in fulminant meningococcal septicemia is predominantly caused by alternative pathway activation.
    Brandtzaeg P; Høgåsen K; Kierulf P; Mollnes TE
    J Infect Dis; 1996 Mar; 173(3):647-55. PubMed ID: 8627028
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Polyacrylamide gel electrophoresis analysis of lipopolysaccharide from Pseudomonas aeruginosa growing planktonically and as biofilm.
    Giwercman B; Fomsgaard A; Mansa B; Høiby N
    FEMS Microbiol Immunol; 1992 Apr; 4(4):225-9. PubMed ID: 1599708
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Human polymorphonuclear leukocyte response to Pseudomonas aeruginosa grown in biofilms.
    Jensen ET; Kharazmi A; Lam K; Costerton JW; Høiby N
    Infect Immun; 1990 Jul; 58(7):2383-5. PubMed ID: 2114367
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Immunological assessment of the pathogenesis of septic-MOF: relationship between complement activation and changes in neutrophil functions].
    Goya T; Doi F; Morisaki T; Torisu M; Shimura H
    Nihon Geka Gakkai Zasshi; 1991 Sep; 92(9):1304-6. PubMed ID: 1944211
    [TBL] [Abstract][Full Text] [Related]  

  • 56. NETosing Neutrophils Activate Complement Both on Their Own NETs and Bacteria via Alternative and Non-alternative Pathways.
    Yuen J; Pluthero FG; Douda DN; Riedl M; Cherry A; Ulanova M; Kahr WH; Palaniyar N; Licht C
    Front Immunol; 2016; 7():137. PubMed ID: 27148258
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Serum-induced lysis of Pseudomonas aeruginosa.
    Meshulam T; Verbrugh H; Verhoef J
    Eur J Clin Microbiol; 1982 Feb; 1(1):1-6. PubMed ID: 6816583
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pseudomonas aeruginosa lipopolysaccharides and pathogenesis.
    Goldberg JB; Pler GB
    Trends Microbiol; 1996 Dec; 4(12):490-4. PubMed ID: 9004407
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Complement componenets, C3 and factors B, in the blood of patients with acute ischemic stroke].
    Aĭvazian VA; Boiadzhian AS; Manukian LA; Avetisian GV; Grigorian GS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2005; Suppl 15():57-60. PubMed ID: 16447555
    [TBL] [Abstract][Full Text] [Related]  

  • 60. C3e: an acidic fragment of human C3 with leukocytosis-inducing activity.
    Ghebrehiwet B; Müller-Eberhard HJ
    J Immunol; 1979 Aug; 123(2):616-21. PubMed ID: 110877
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.